Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Principal Investigator
Name
Julia Publicover
Degrees
MSc
Institution
University Health Network
Position Title
Program Manager
Email
About this CDAS Project
Study
NLST (Learn more about this study)
Project ID
NLST-575
Initial CDAS Request Approval
Oct 24, 2019
Title
Lung cancer imaging biomarker development on computed tomography using artificial intelligence
Summary
The University Health Network's Quantitative Imaging for Personalized Cancer Medicine (QIPCM) Imaging core lab and Altis Labs, Inc, a Toronto-based company which is submitting its own project proposal and DTA for this research project, are collaborating to develop and validate novel lung cancer imaging biomarkers using deep learning. This project will entail labeling the data to develop detection, segmentation, and classification algorithms. We will explore the potential clinical utility when incorporating algorithms into physician workflow and real-world clinical data. Our goal is to develop robust algorithms that can be applied in clinical settings to improve patient care and outcomes.
Aims

- develop state-of-the-art nodule detection and classification algorithms
- test algorithms' utility on screening, diagnostic, and staging workflows

Collaborators

UHN (Quantitative Imaging for Personalized Cancer Medicine) and Altis Labs' R&D team.